(4-Ethyltetrahydro-2H-pyran-4-yl)methanamine(1142202-08-1)
- Name: (4-Ethyltetrahydro-2H-pyran-4-yl)methanamine
- Synonyms:(4-Ethyltetrahydro-2H-pyran-4-yl)methanamine
- Molecular Formula:C8H17NO
- Molecular Weight:143.22668
- CAS Registry Number:1142202-08-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1142202-08-1 (4-Ethyltetrahydro-2H-pyran-4-yl)methanamine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1142202-08-1 (4-Ethyltetrahydro-2H-pyran-4-yl)methanamine
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.1142202-08-1 1-(4-ethyloxan-4-yl)methanamine;1142202-08-1
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.1142202-08-1 [(4-Ethyltetrahydro-2H-pyran-4-yl)methyl]amine
Assay:97% Appearance:white to light yellow crystal powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1086599-35-0/1-(2-BroMo-4-fluorophenyl)ethanaMine
- 1270300-71-4/Cbz-2-BroMo-D-Phenylalanine
- 28809-54-3/5α-Cholestane-2α,19-diol
- 870823-08-8/(S)-ethyl 4-(1-(3-(3,5-dichlorophenyl)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)ethyl)benzoate
- 54965-25-2/1-Butene-1,4-diol di(trifluoroacetate)
- 532404-08-3/3-[[[(2,4-DICHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-2-METHYL-BENZOIC ACID
- 1146411-63-3/4-(2,3-dichlorobenzoyl)-2-piperazinone
- 1369783-74-3/4-tert-butyl-3-(cyclopropylmethoxy)aniline
- 36972-83-5/3-Pyridinamine,N-(trimethylsilyl)-4-[(trimethylsilyl)oxy]-(9CI)
- 337919-65-0/1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-4-PIPERIDINECARBOXYLIC ACID
- 188193-23-9/Carbamic acid, (1-oxo-4-pentenyl)-, ethyl ester (9CI)
- 438252-47-2/Benzo[b]thiophen-2-amine, 4,5,6,7-tetrahydro-3-(4-pyridinyl)- (9CI)
- 1228665-49-3/t-Butyl 6-(3-((tert-butyldimethylsilyloxy)methyl)-pyrrolidin-1-yl)-2-fluoropyridin-3-ylcarbamate
- 1190318-97-8/3-AMino-6-Methoxy-7-azaindole
- 169673-97-6/6-CHLORO-5-FLUORO-3-METHYLINDOLE
- 1171619-76-3/2-Amino-6-methoxy-3-propylquinoline hydrochloride
- 152140-65-3/(R,R)-ANDEN-Phenyl Trost Ligand,(+)-(11R,12R)Bis[2′-(diphenylphosphino)benzamido]-9,10-dihydro-9,10-ethanoanthracene, (11R,12R)-N,N′-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosp
- 1217710-65-0/(S)-Citalopram-d6 N-Oxide
- 1217679-71-4/METHYL (2S,4S)-4-(2-ETHOXYPHENOXY)-2-PYRROLIDINECARBOXYLATE
- 1142202-08-1/(4-Ethyltetrahydro-2H-pyran-4-yl)methanamine
- 1204324-18-4/(2S,5S)-1-{[(2S,5S)-2,5-Diethylpyrrolidin-1-yl]methylene}-2,5-diethylpyrrolidinium tetrafluoroborate, min. 97%
- 888499-97-6/(5-cyclopropyl-2-methoxypyridin-3-yl)methanol
- 181217-39-0/Fenoldopam hydrochloride
- 2835-66-7/3-Aminobenzaldehyde oxime
- 675596-34-6/4'-TRIFLUOROMETHOXY-BIPHENYL-3-CARBALDEHYDE
- 733759-22-3/Pyrrolidine, 2-sec-butyl-1-methyl- (4CI)
- 910654-45-4/3-(4-TRIFLUOROMETHYLSULFANYL-PHENYL)-PROPIONIC ACID ETHYL ESTER
- 329217-27-8/Piperazine, 1-(2,3-dimethoxypropyl)- (9CI)
- 38653-51-9/2-[(1-Methylene-2-propenyl)oxy]ethanol
- 725234-49-1/1-O-TOLYLAMINO-CYCLOPENTANECARBOXYLIC ACID